Abstract
Familial Mediterranean fever disease (FMF) is an autosomal recessively inherited disease characterized by recurrent, self-limited febrile episodes (attacks) with serositis, synovitis, and occasionally skin involvement. The disease primarily affects people of eastern Mediterranean descent, typically presenting at age <20. AA amyloidosis is the most serious complication of FMF and can be life-threatening. Daily colchicine is considered standard of care, and is expected to prevent attacks and amyloidosis in most patients. Turkey has the highest prevalence with 0.1% in general population.
Highlights
Familial Mediterranean fever disease (FMF) is an autosomal recessively inherited disease characterized by recurrent, self-limited febrile episodes with serositis, synovitis, and occasionally skin involvement
Turkey has the highest prevalence with 0.1% in general population
Published: 28 September 2015 doi:10.1186/1546-0096-13-S1-P90 Cite this article as: Turgay et al.: Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
Summary
Familial Mediterranean fever disease (FMF) is an autosomal recessively inherited disease characterized by recurrent, self-limited febrile episodes (attacks) with serositis, synovitis, and occasionally skin involvement. The disease primarily affects people of eastern Mediterranean descent, typically presenting at age
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
